The newly FDA approved NeuRx Diaphragm Pacing System® introduces groundbreaking neurostimulation technology designed to help spinal cord injury patients decrease their dependency on mechanical ventilation – enhancing their quality of life.

The NeuRx DPS® uses a minimally invasive outpatient procedure to establish a deeper and more comfortable breathing pattern.

New Now approved for treating ALS (Lou Gehrig's Disease) in the United States. To find out more, see our expanded ALS section or contact an ALS treatment center.

With the FDA’s approval, Spinal Cord Injury/Quadriplegia patients and their caregivers throughout the U.S. can now access this technology that was previously only available to clinical trial participants.

“ Synapse Biomedical and NSCIA are proud to partner on patient, caregiver and professional education to the spinal cord community. www.spinalcord.org